Vol.

No.

July 07, 2023Jul 07, 2023

DOWNLOAD THE PDF

Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunity The finding may alter biology textbooks

Cover Story

Conversation with The Cancer Letter

Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunity

The finding may alter biology textbooks

By Jacquelyn Cobb

Scientists used to dismiss the notion that the Y chromosome plays a role in cancer.

Clinical

Can ctDNA be used as an endpoint for cancer drug development?
Friends collaboration to present initial results July 11

By Matthew Bin Han Ong

Guest Editorial

Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities

By Kim F. Rhoads, Folakemi T. Odedina, Monica L. Baskin, Vanessa B. Sheppard, Hayley S. Thompson, Kimlin Tam Ashing and Charnita Zeigler-Johnson

Free Obituary

Susan Love, a transformative leader in breast cancer movement, dies at 75
She intuitively understood the right thing to do—and then just did it

By Frances M. Visco

Free In the Archives

Remembering Susan Love, breast cancer oncologist and advocate

In Brief

David W. Craig named founding chair of Department of Integrative Translational Sciences at City of Hope

Crapo, Bennet, Cardin, and Scott introduce legislation to expand coverage of MCEDs

Clinical Roundup

Datopotamab deruxtecan improves PFS in advanced NSCLC, phase III trial shows

Drugs & Targets

FDA grants priority review to zolbetuximab for gastroesophageal junction adenocarcinoma

NCI Trials

NCI Trials for July 2023

The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 42 - November 08, 2024